CBDNewsBreaks – Positive Media Attention Recognizes InMed Pharmaceuticals’ (IMLFF) Operational Developments, Leadership Team
Ongoing media coverage continues to recognize and highlight the achievements of InMed Pharmaceuticals, Inc. (OTCQB: IMLFF), a preclinical biopharmaceutical company focused on developing therapies through research and development into the pharmacology of cannabinoids and drug delivery systems. The company was featured as a “Cannabis Runner” by Insider Financial earlier this year, and Forbes also more recently released an article calling InMed “more than just another cannabis drug company.” “Although the company’s pipeline is expected to generate a significant amount of attention in 2018, InMed Pharmaceuticals’ manufacturing system and database are catching the eye of investors and biotech companies. THC and…